Your browser doesn't support javascript.
loading
Kidney bioengineering in regenerative medicine: An emerging therapy for kidney disease.
Lin, Yi-Qian; Wang, Li-Ren; Pan, Liang-Liang; Wang, Hui; Zhu, Gui-Qi; Liu, Wen-Yue; Wang, Jiang-Tao; Braddock, Martin; Zheng, Ming-Hua.
Afiliación
  • Lin YQ; Department of Infection and Liver Diseases, Liver Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China; Renji School of Wenzhou Medical University, Wenzhou, China.
  • Wang LR; Department of Infection and Liver Diseases, Liver Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China; School of the First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, China.
  • Pan LL; School of Laboratory and Life Science, Wenzhou Medical University, Wenzhou, China.
  • Wang H; Department of Neurosurgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Zhu GQ; Department of Infection and Liver Diseases, Liver Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China; School of the First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, China.
  • Liu WY; Department of Endocrinology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Wang JT; Department of Infection and Liver Diseases, Liver Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China; School of the First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, China.
  • Braddock M; Global Medicines Development, AstraZeneca R&D, Alderley Park, United Kingdom.
  • Zheng MH; Department of Infection and Liver Diseases, Liver Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China; Institute of Hepatology, Wenzhou Medical University, Wenzhou, China. Electronic address: zhengmh@wmu.edu.cn.
Cytotherapy ; 18(2): 186-97, 2016 Feb.
Article en En | MEDLINE | ID: mdl-26596504
The prevalence of end-stage renal disease is emerging as a serious worldwide public health problem because of the shortage of donor organs and the need to take lifelong immunosuppressive medication in patients who receive a transplanted kidney. Recently, tissue bioengineering of decellularization and recellularization scaffolds has emerged as a novel strategy for organ regeneration, and we review the critical technologies supporting these methods. We present a summary of factors associated with experimental protocols that may shed light on the future development of kidney bioengineering and we discuss the cell sources and bioreactor techniques applied to the recellularization process. Finally, we review some artificial renal engineering technologies and their future prospects, such as kidney on a chip and the application of three-dimensional and four-dimensional printing in kidney tissue engineering.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Regeneración / Ingeniería de Tejidos / Medicina Regenerativa / Regeneración Tisular Dirigida / Fallo Renal Crónico Tipo de estudio: Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2016 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Regeneración / Ingeniería de Tejidos / Medicina Regenerativa / Regeneración Tisular Dirigida / Fallo Renal Crónico Tipo de estudio: Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2016 Tipo del documento: Article País de afiliación: China